An Extension Study Administering YM155 to Subjects Previously Enrolled in Another Protocol Administering YM155
Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
This protocol is open to subjects previously enrolled in and who had completed a Phase I or
Phase II study administering YM155. Subjects who are receiving benefit from treatment with
YM155 are eligible after completing the previous study.